EMEND 125 mg Powder for Oral Suspension: Uses and Guide
Quick summary EMEND 125 mg powder for oral suspension contains aprepitant and is used to help prevent nausea and vomiting linked to chemotherapy in children. It is given as part of a treatment plan...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
EMEND 125 mg powder for oral suspension contains aprepitant and is used to help prevent nausea and vomiting linked to chemotherapy in children. It is given as part of a treatment plan set by a healthcare professional.
Medical disclaimer: This article is for general information only and does not replace advice from a doctor, pharmacist, or the official patient leaflet. Always follow the prescribed instructions for this medicine and the child’s oncology team.
What is EMEND 125 mg powder for oral suspension?
EMEND 125 mg powder for oral suspension contains aprepitant, an NK1 receptor antagonist. It is used to help prevent nausea and vomiting associated with chemotherapy.
The original content states that this formulation is suitable for children aged 6 months to less than 12 years. It is supplied as a sachet and is designed to be made into an oral suspension for easier administration.
What is EMEND used for?
EMEND is used in pediatric oncology care to help prevent nausea and vomiting caused by chemotherapy, including:
- Highly emetogenic chemotherapy
- Moderately emetogenic chemotherapy
Reducing nausea and vomiting can help children tolerate treatment more comfortably.
How does aprepitant work?
Aprepitant works by blocking substance P at NK1 receptors, which are involved in the vomiting reflex. This action helps reduce chemotherapy-related nausea and vomiting.
The original content also notes that aprepitant interacts with the CYP3A4 enzyme, so other medicines should be reviewed by a healthcare professional.
How is EMEND 125 mg powder for oral suspension given?
This medicine should be given according to the instructions from the child’s healthcare team. The original content states that it is typically administered:
- About one hour before chemotherapy
- On Days 1, 2, and 3 of the chemotherapy cycle
- Based on the child’s body weight
Because the dose and timing are individualized, caregivers should check the prescription label and the official leaflet carefully.
Preparation and mixing
The original content says the powder should be mixed correctly before use. If you are preparing it, follow the exact instructions provided by the healthcare team or leaflet, including the amount of water to use.
Do not guess the mixing method if the instructions are unclear. Ask a pharmacist or clinician to confirm the preparation steps.
What side effects are mentioned in the original content?
The original content lists the following possible side effects:
- Nausea and vomiting
- Fatigue and dizziness
- Diarrhea or constipation
If any side effect seems severe, persistent, or unusual, contact the child’s healthcare team for advice.
What should be checked before use?
The original content highlights a few important points to verify before use:
- Known hypersensitivity to aprepitant or any component
- Use in children under 6 months
- Use in children weighing less than 6 kg
- Possible concerns in severe hepatic impairment
Because this medicine may interact with other drugs, the full medication list should be reviewed by a healthcare professional.
Key points for caregivers
When EMEND is prescribed, it is usually part of a broader anti-nausea plan. Caregivers may find it helpful to confirm:
- When the dose should be given
- How the powder should be mixed
- Whether any other medicines are being used at the same time
- What to do if a dose is missed or vomited after administration
These details should come from the prescribing team or official leaflet.
EMEND and dexamethasone
The original content says EMEND can be used alongside dexamethasone. However, timing and dosing should be confirmed by the healthcare professional managing the chemotherapy plan.
Do not make changes to either medicine without medical advice.
Safety reminder
Because this medicine is used in children receiving chemotherapy, safety checks matter. Always use the prescribed dose, follow the exact preparation instructions, and ask a pharmacist or doctor to review any other medicines, including over-the-counter products and supplements.
Frequently asked questions
▸ What is EMEND 125 mg powder for oral suspension used for?
It is used to help prevent nausea and vomiting linked to chemotherapy in children.
▸ What active ingredient does EMEND contain?
EMEND 125 mg powder for oral suspension contains aprepitant.
▸ How is EMEND usually timed around chemotherapy?
The original content says it is typically given about one hour before chemotherapy and on Days 1, 2, and 3 of the cycle, according to the prescribed plan.
▸ Can EMEND be mixed at home?
The powder is intended to be made into an oral suspension, but the exact preparation steps should be followed from the official instructions or a pharmacist’s guidance.
▸ What side effects are mentioned for EMEND?
The original content mentions nausea, vomiting, fatigue, dizziness, diarrhea, and constipation.
▸ Can EMEND interact with other medicines?
Yes. The original content notes interaction potential through CYP3A4, so other medicines should be checked by a healthcare professional.
Summary
EMEND 125 mg powder for oral suspension is an aprepitant-based medicine used to help prevent chemotherapy-related nausea and vomiting in children. Its use, preparation, and timing should always follow the prescribing team’s instructions and the official leaflet.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.